CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment / Bandinelli F;Del Rosso A;Gabrielli A;Giacomelli R;Bartoli F;Guiducci S;Matucci Cerinic M. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - STAMPA. - 30(2 Suppl 71):(2012), pp. S44-S49.
CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
GUIDUCCI, SERENA;MATUCCI CERINIC, MARCO
2012
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.